[https://ir.curaleaf.com].Curaleaf IR X Account: [https://x.com/Curaleaf_IR]Investor Relations Website: [https://ir.curaleaf.com/]Contact Information:Investor Contact: Curaleaf Holdings, Inc.Camilo Lyon, Chief Investment Officer [[email protected]]Media Contact:MATTIO Communications [[email protected]]DisclaimerThis press release contains "forward-looking information" and "forward-looking statements" within the meaning of Canadian securities laws and securities laws of the U.S. (together, "forward- looking ...

Core Insights - Curaleaf has opened a new dispensary in Findlay, Ohio, marking its fifth location in the state and increasing its total national retail count to 162 [1] Company Expansion - The new dispensary is located at 2205 Tiffin Avenue, Findlay, OH 45840, aimed at enhancing access to high-quality cannabis for both medical patients and adult-use customers in Northwest Ohio [1] - Curaleaf's expansion in Ohio reflects its commitment to the state's evolving cannabis landscape, as stated by Boris Jordan, Chairman and CEO [1] Product Offering - Curaleaf Findlay will offer a broad selection of premium cannabis products, including brands like Select BRIQ all-in-one vape, Find, and Grassroots high-quality flower [1] Operational Details - The dispensary will operate from 9:00 AM to 8:00 PM ET, Monday through Saturday, and 9:00 AM to 7:00 PM ET on Sundays [1] - Curaleaf currently operates retail locations in Cuyahoga Falls, Findlay, Girard, Lima, and Newark within Ohio [1] Company Overview - Curaleaf Holdings, Inc. is recognized as a leading international provider of consumer cannabis products, focusing on quality, expertise, and reliability [1] - The company operates a strong distribution network across Europe, Canada, and Australasia, integrating pioneering science and research with advanced cultivation and production methods [1]

3 Marijuana Stocks Investors Have Taken A Chance OnThe cannabis industry has undergone many breakthrough points of innovation. With cultivators and legal operators keeping the focus on the future and working with its political landscape. Cannabis is a profitable crop similar to tobacco or corn. From medicine to clothing and many other items in between, the need and use for cannabis keep growing. This idea has enabled others to find a way to get involved. Whether it be starting your own legal cannabis busine ...

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Curaleaf Holdings, Inc. due to lower revenues, with a focus on how actual results will compare to estimates [1][2]. Earnings Expectations - Curaleaf is expected to report a quarterly loss of $0.08 per share, reflecting a significant year-over-year change of -500% [3]. - Revenues are projected to be $327.84 million, which is a decrease of 1% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 2.22% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Curaleaf is lower than the Zacks Consensus Estimate, leading to an Earnings ESP of -3.23% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from consensus estimates, with a strong predictive power for positive readings [7][8]. - Curaleaf's current Zacks Rank is 4, which complicates the prediction of an earnings beat [11]. Historical Performance - In the last reported quarter, Curaleaf was expected to post a loss of $0.07 per share but actually reported a loss of -$0.06, resulting in a surprise of +14.29% [12]. - Over the past four quarters, Curaleaf has beaten consensus EPS estimates three times [13]. Conclusion - Curaleaf Holdings, Inc. does not appear to be a strong candidate for an earnings beat, and investors should consider other factors when making decisions regarding the stock ahead of the earnings release [16].

Core Viewpoint - Curaleaf Holdings, Inc. has successfully closed a private placement of $500 million in senior secured notes, which will support its global growth initiatives and enhance capital flexibility in the cannabis sector [1]. Group 1: Financial Details - The private placement consists of $500 million aggregate principal amount of 11.5% senior secured notes due February 18, 2029 [1]. - The company will use the net proceeds to support global growth initiatives and pay transaction fees and expenses [1]. - The notes were issued at 100% of face value and are senior secured obligations, payable semi-annually until maturity [1]. Group 2: Strategic Implications - The successful closing of this private placement is seen as a strong endorsement of Curaleaf's long-term strategy and vision [1]. - The company aims to accelerate its global expansion and capture strategic opportunities in the international cannabis market [1]. - The issuance marks a pivotal moment for the cannabis sector, indicating renewed institutional demand and confidence in long-term growth [1]. Group 3: Regulatory and Market Context - The notes were offered on a private placement basis in Canada and the United States, adhering to applicable securities laws [1]. - Seaport Global Securities, LLC acted as the lead placement agent, with ATB Cormark Capital Markets as the co-placement agent [1]. - The notes are subject to a customary four-month hold period under Canadian securities laws [1].

Core Viewpoint - Curaleaf Holdings, Inc. has announced a change in the date of its special meeting to seek shareholder approval for a proposed arrangement involving the continuation of the Company from British Columbia, Canada to Delaware, USA, aiming to enhance shareholder participation and streamline the approval process [1]. Group 1: Meeting Details - The special meeting was initially scheduled for February 23, 2026, but has been postponed to align with the annual general meeting expected in the second quarter of 2026 [1]. - The Company believes that combining the special meeting with the annual general meeting will promote greater shareholder participation and result in a more cost-effective use of resources [1]. Group 2: Company Overview - Curaleaf is a leading international provider of consumer cannabis products, known for its quality, expertise, and reliability [1]. - The Company operates under various brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company, providing industry-leading service and product selection across medical and adult-use markets [1]. - Curaleaf has a strong presence in all stages of the supply chain and a unique distribution network throughout Europe, Canada, and Australasia [1].

Industry Overview - The cannabis industry is currently in a transitional phase, with over half of the US legalizing cannabis in some form, and the potential for all 50 states to establish a legal market, which could significantly impact marijuana stocks [1][2] - The sector has evolved, encompassing recreational, medical, and ancillary markets, as well as textile applications using hemp, indicating robust global growth [2] Market Outlook - Investors are speculating on how and when legal reforms will positively impact the sector, with positive speculation potentially driving trading momentum [3] - Proper preparation and careful observation of market trends can lead to profitable investment opportunities in marijuana stocks [3] Company Highlights - **Glass House Brands Inc.**: Operates as an integrated cannabis company in the US, with three segments: Retail, Wholesale Biomass, and Cannabis-Related Consumer Packaged Goods. The company appointed Alison Payne to its Board of Directors on January 27, 2026, enhancing its branding and marketing capabilities [4][5] - **Ayr Wellness Inc.**: Engages in the cultivation, manufacturing, and retailing of cannabis products. Recently, the company announced the departure of Lou Karger as Director and Chair of the Board, acknowledging his contributions to the company's development [8][9] - **Curaleaf Holdings, Inc.**: Produces and distributes cannabis products both domestically and internationally. The company has secured commitments for a private placement of US$500 million in senior secured notes, which will be used to refinance existing debt and support global growth initiatives [9][12]

Core Viewpoint - Curaleaf Holdings, Inc. has announced a private placement of US$500 million in senior secured notes, which will be used to refinance existing debt and support global growth initiatives [1][2][3] Group 1: Offering Details - The Offering consists of 11.5% senior secured notes due February 1, 2029, issued at 100% of face value [2] - Proceeds will refinance US$475 million of existing senior secured notes due December 15, 2026, with US$457 million currently outstanding [1] - The Offering is expected to close around February 18, 2026, subject to customary closing requirements [2] Group 2: Investor Demand and Market Position - The Offering has been oversubscribed, marking it as the largest note offering in the U.S. cannabis industry to date [3] - Ten first-time cannabis lenders are participating, indicating strong institutional investor confidence in Curaleaf [3] - The transaction is expected to strengthen the company's balance sheet and extend maturities to 2029, providing flexibility for growth opportunities [3] Group 3: Company Overview - Curaleaf is a leading international provider of consumer cannabis products, known for quality and reliability [6] - The company operates across all stages of the supply chain and has a strong distribution network in Europe, Canada, and Australasia [6] - Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF [6]

CHICAGO--(BUSINESS WIRE)--Turn, the AI-native workforce screening and compliance infrastructure company, today announced that it has been selected by Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a leading global cannabis operator, to support background screening across Curaleaf's workforce. "Turn's technology-driven approach supports our operational and compliance requirements while enabling a consistent hiring experience across the organization,†said Camilo Lyon, Chief Investment Officer at Curaleaf ...

Industry Overview - The U.S. cannabis sector is at a critical inflection point as of February 2026, with improved market sentiment but selective investor interest [1] - Long-term demand for cannabis continues to grow despite price volatility, with state-level legalization expanding and medical programs remaining stable [2] - Profitability is now prioritized over rapid expansion, leading companies to tighten operations and protect margins [3] Company Highlights Trulieve Cannabis Corp. (TCNNF) - Trulieve is a dominant cannabis operator in the U.S., operating a vertically integrated business model across cultivation, processing, distribution, and retail sales [4] - The company has a significant presence in Florida, which serves as its core revenue engine, while also expanding into states like Pennsylvania, Arizona, Maryland, Ohio, and Connecticut [5] - As of early 2026, Trulieve operates over 230 dispensaries nationwide, enhancing brand visibility and customer loyalty [7] - The company focuses on disciplined expansion, targeting profitable markets to remain competitive during industry slowdowns [9] - Financially, Trulieve emphasizes cash flow and balance sheet strength, with stable revenue and healthy gross margins despite pricing pressure [10] - Management has taken steps to address near-term debt obligations, improving liquidity and reducing financial risk [11] - Trulieve continues generating meaningful EBITDA and maintains sufficient cash reserves for selective growth [12] - The company is well-positioned for future growth as regulatory clarity improves [13] Curaleaf Holdings, Inc. (CURLF) - Curaleaf is the largest cannabis company in the U.S. by revenue, operating across numerous states and markets, providing diversification and risk mitigation [13] - The company operates over 160 dispensaries, with a significant retail presence in Florida and strong positions in New Jersey, New York, Arizona, and Illinois [14] - Curaleaf focuses on operational efficiency, optimizing existing assets rather than aggressive expansion, which helps preserve margins [17] - Financially, Curaleaf generates over a billion dollars in annual revenue, with recent trends showing stabilization and improved gross margins [18] - The company is focused on reducing expenses and streamlining operations, with debt management being a priority [19] - While net profitability remains elusive, losses have narrowed, reflecting disciplined spending and operational focus [20] Verano Holdings Corp. (VRNOF) - Verano is a vertically integrated cannabis operator with a footprint in key markets such as Illinois, Florida, New Jersey, Pennsylvania, and Arizona [21] - The company operates retail dispensaries under brands like Zen Leaf and MÜV, maintaining a strategically placed retail network [22] - Verano emphasizes product quality and consistent branding to attract loyal customers, balancing retail growth with operational discipline [24] - Financially, Verano has faced revenue pressure but has focused on cost control to protect margins [25] - The company has significant net losses due to ongoing investments and restructuring costs, but prioritizes operational efficiency [26] - Verano is considered a higher-risk, higher-reward operator, with potential upside if market conditions improve [26]